Search results for "Highlights"
Combination therapy for IBD carries higher infection risk than monotherapy
Monotherapy for inflammatory bowel disease (IBD) with an immunosuppressive agent was associated with a lower risk of serious infection than a tumor necrosis factor (TNF) antagonist alone or an anti-TNF plus an immunosuppressive agent, according to a meta-analysis.
https://gastroenterology.acponline.org/archives/2019/03/22/2.htm
22 Mar 2019
COVID-19 guidance released for managing IBD patients, endoscopic procedures
The American Gastroenterological Association released new guidance for clinicians caring for patients with inflammatory bowel disease (IBD) and those performing endoscopic procedures, and two recent studies looked at GI symptoms in patients with COVID-19.
https://gastroenterology.acponline.org/archives/2020/04/24/1.htm
24 Apr 2020
Individual or group hypnotherapy associated with relief from IBS
Although hypnotherapy did not improve quality of life, psychological symptoms, cognition, self-efficacy, or irritable bowel syndrome (IBS) symptoms significantly more than an educational support program, it may provide relief to patients by changing their perception of IBS.
https://gastroenterology.acponline.org/archives/2018/12/28/3.htm
28 Dec 2018
Score predicts hepatic decompensation among patients with NAFLD
Age, presence of diabetes, and platelet count were significant predictors of hepatic events up to 12 years from the time of nonalcoholic fatty liver disease (NAFLD) diagnosis, a retrospective study found.
https://gastroenterology.acponline.org/archives/2020/03/27/1.htm
27 Mar 2020
Statins associated with lower risk for postcolonoscopy colorectal cancer
The primary outcome of the retrospective cohort study was postcolonoscopy colorectal cancer within three years, defined as colorectal cancer diagnosed within six and 36 months after negative findings on index colonoscopy.
https://gastroenterology.acponline.org/archives/2019/03/22/3.htm
22 Mar 2019
PPI prophylaxis didn't affect 90-day mortality rates among ICU patients
Gastrointestinal bleeds were less common among at-risk ICU patients who received IV pantoprazole instead of placebo, but rates of clinically important events were similar overall.
https://gastroenterology.acponline.org/archives/2018/10/26/2.htm
26 Oct 2018
Early-onset colorectal cancer increases sharply between ages 49 and 50, study finds
According to U.S. registry data, incidence of colorectal cancer increased 46.1% from age 49 years to age 50 years, from 34.9 to 51.0 per 100,000 population.
https://gastroenterology.acponline.org/archives/2020/02/28/1.htm
28 Feb 2020
Guideline recommends standardized management of mild to moderate ulcerative colitis
The guideline focuses on oral and topical 5-aminosalicylic acid medications, rectal corticosteroids, and oral budesonide in patients with mild to moderate disease.
https://gastroenterology.acponline.org/archives/2018/12/28/2.htm
28 Dec 2018
Halting one ulcerative colitis treatment after escalating to new drug may be feasible, study finds
Patients with ulcerative colitis treated with 5-aminosalicylates who require escalation to anti-tumor necrosis factor-alpha (anti-TNF) therapy may be able to safely discontinue the first drug.
https://gastroenterology.acponline.org/archives/2018/11/27/3.htm
27 Nov 2018
Antidepressants may mitigate link between inflammatory bowel disease and depression
Patients with depression had more than double the risk of developing Crohn's disease or ulcerative colitis over a median follow-up of more than six years.
https://gastroenterology.acponline.org/archives/2018/10/26/3.htm
26 Oct 2018